Marta Hałasa

660 total citations
22 papers, 453 citations indexed

About

Marta Hałasa is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Marta Hałasa has authored 22 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Oncology. Recurrent topics in Marta Hałasa's work include Histone Deacetylase Inhibitors Research (10 papers), Epigenetics and DNA Methylation (8 papers) and Berberine and alkaloids research (3 papers). Marta Hałasa is often cited by papers focused on Histone Deacetylase Inhibitors Research (10 papers), Epigenetics and DNA Methylation (8 papers) and Berberine and alkaloids research (3 papers). Marta Hałasa collaborates with scholars based in Poland, Finland and United States. Marta Hałasa's co-authors include Anna Wawruszak, Andrzej Stepulak, Estera Okoń, Wirginia Kukuła‐Koch, Joanna Kałafut, Alicja Przybyszewska-Podstawka, Adolfo Rivero‐Müller, Lidia Borkiewicz, Karolina Okła and Małgorzata Guz and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Cellular and Molecular Life Sciences.

In The Last Decade

Marta Hałasa

21 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marta Hałasa Poland 11 330 107 46 41 29 22 453
Estera Okoń Poland 9 314 1.0× 96 0.9× 87 1.9× 36 0.9× 38 1.3× 22 455
Vijay S. Thakur United States 11 342 1.0× 102 1.0× 85 1.8× 37 0.9× 35 1.2× 13 575
Dong Hou China 11 274 0.8× 86 0.8× 78 1.7× 54 1.3× 30 1.0× 12 489
Nikhil Vad United States 10 246 0.7× 72 0.7× 56 1.2× 50 1.2× 19 0.7× 14 420
Wei Ya China 7 274 0.8× 68 0.6× 66 1.4× 44 1.1× 24 0.8× 29 459
Marta Hałas‐Wiśniewska Poland 11 231 0.7× 76 0.7× 60 1.3× 75 1.8× 13 0.4× 32 466
Ajeet Kumar Verma India 11 187 0.6× 72 0.7× 47 1.0× 38 0.9× 15 0.5× 16 349
Mi‐Hyeon Jeong South Korea 13 264 0.8× 78 0.7× 65 1.4× 21 0.5× 16 0.6× 18 400
Jia-Ni Lin Taiwan 9 262 0.8× 45 0.4× 69 1.5× 32 0.8× 53 1.8× 16 481
Addanki P. Kumar United States 9 265 0.8× 69 0.6× 87 1.9× 66 1.6× 35 1.2× 10 432

Countries citing papers authored by Marta Hałasa

Since Specialization
Citations

This map shows the geographic impact of Marta Hałasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Hałasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Hałasa more than expected).

Fields of papers citing papers by Marta Hałasa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Hałasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Hałasa. The network helps show where Marta Hałasa may publish in the future.

Co-authorship network of co-authors of Marta Hałasa

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Hałasa. A scholar is included among the top collaborators of Marta Hałasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Hałasa. Marta Hałasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kloc, Małgorzata, Marta Hałasa, J. Wosik, & Rafik M. Ghobrial. (2025). Gadolinium-based MRI contrast agent effects on calcium signaling and actin-dependent cell functions. 1(1). 100004–100004. 2 indexed citations
2.
Hałasa, Marta, Anna Wawruszak, Klaudia Brodaczewska, et al.. (2025). Loss of Sirtuin 7 impairs cell motility and proliferation and enhances S-phase cell arrest after 5-fluorouracil treatment in head and neck cancer. Scientific Reports. 15(1). 2123–2123. 1 indexed citations
3.
Hałasa, Marta, Ahmed Uosef, Arijita Subuddhi, et al.. (2024). Gadolinium retention effect on macrophages — a potential cause of MRI contrast agent Dotarem toxicity. Cell and Tissue Research. 397(1). 51–60. 1 indexed citations
4.
Kloc, Małgorzata, Marta Hałasa, Jacek Z. Kubiak, & Rafik M. Ghobrial. (2024). Invertebrate Immunity, Natural Transplantation Immunity, Somatic and Germ Cell Parasitism, and Transposon Defense. International Journal of Molecular Sciences. 25(2). 1072–1072. 4 indexed citations
5.
Kloc, Małgorzata, Marta Hałasa, & Rafik M. Ghobrial. (2024). Macrophage niche imprinting as a determinant of macrophage identity and function. Cellular Immunology. 399-400. 104825–104825. 2 indexed citations
6.
Hałasa, Marta & Anna Wawruszak. (2024). Unlocking Macrophage Secrets: Histone Deacetylases in Chronic Transplant Rejection. Results and problems in cell differentiation. 74. 297–313.
7.
Hałasa, Marta, Ewa Pięta, Wojciech M. Kwiatek, et al.. (2023). Molecular tracking of interactions between progenitor and endothelial cells via Raman and FTIR spectroscopy imaging: a proof of concept of a new analytical strategy for in vitro research. Cellular and Molecular Life Sciences. 80(11). 329–329. 2 indexed citations
8.
Wawruszak, Anna, Jarogniew J. Łuszczki, Marta Hałasa, et al.. (2021). Sensitization of MCF7 Cells with High Notch1 Activity by Cisplatin and Histone Deacetylase Inhibitors Applied Together. International Journal of Molecular Sciences. 22(10). 5184–5184. 7 indexed citations
9.
Hałasa, Marta, Jarogniew J. Łuszczki, Magdalena Dmoszyńska‐Graniczka, et al.. (2021). Antagonistic Interaction between Histone Deacetylase Inhibitor: Cambinol and Cisplatin—An Isobolographic Analysis in Breast Cancer In Vitro Models. International Journal of Molecular Sciences. 22(16). 8573–8573. 7 indexed citations
10.
Wawruszak, Anna, et al.. (2021). Vorinostat (SAHA) and Breast Cancer: An Overview. Cancers. 13(18). 4700–4700. 79 indexed citations
11.
Wawruszak, Anna, Marta Hałasa, Estera Okoń, Wirginia Kukuła‐Koch, & Andrzej Stepulak. (2021). Valproic Acid and Breast Cancer: State of the Art in 2021. Cancers. 13(14). 3409–3409. 49 indexed citations
12.
Okoń, Estera, Jarogniew J. Łuszczki, Wirginia Kukuła‐Koch, et al.. (2020). Synergistic or Additive Pharmacological Interactions between Magnoflorine and Cisplatin in Human Cancer Cells of Different Histological Origin. International Journal of Molecular Sciences. 21(8). 2848–2848. 18 indexed citations
13.
Okoń, Estera, Wirginia Kukuła‐Koch, Marta Hałasa, et al.. (2020). Magnoflorine—Isolation and the Anticancer Potential against NCI-H1299 Lung, MDA-MB-468 Breast, T98G Glioma, and TE671 Rhabdomyosarcoma Cancer Cells. Biomolecules. 10(11). 1532–1532. 30 indexed citations
14.
Okoń, Estera, et al.. (2020). Advances in Chemistry and Bioactivity of Magnoflorine and Magnoflorine-Containing Extracts. International Journal of Molecular Sciences. 21(4). 1330–1330. 47 indexed citations
15.
Wawruszak, Anna, Estera Okoń, Witold Jeleniewicz, et al.. (2019). <p>Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties</p>. Cancer Management and Research. Volume 11. 8345–8358. 17 indexed citations
16.
Hałasa, Marta, et al.. (2019). Role of N-terminus in function and dynamics of sirtuin 7: an in silico study. Journal of Biomolecular Structure and Dynamics. 38(5). 1283–1291. 5 indexed citations
17.
Wawruszak, Anna, Joanna Kałafut, Estera Okoń, et al.. (2019). Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells. Cancers. 11(2). 148–148. 85 indexed citations
18.
Wawruszak, Anna, Jarogniew J. Łuszczki, Joanna Kałafut, et al.. (2019). Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity—An Isobolographic Analysis. International Journal of Molecular Sciences. 20(15). 3663–3663. 17 indexed citations
19.
Hałasa, Marta, Anna Wawruszak, Alicja Przybyszewska-Podstawka, et al.. (2019). H3K18Ac as a Marker of Cancer Progression and Potential Target of Anti-Cancer Therapy. Cells. 8(5). 485–485. 48 indexed citations
20.
Łuszczki, Jarogniew J., Małgorzata Guz, Krystyna Skalicka‐Woźniak, et al.. (2018). Combination of Osthole and Cisplatin Against Rhabdomyosarcoma TE671 Cells Yielded Additive Pharmacologic Interaction by Means of Isobolographic Analysis. Anticancer Research. 38(1). 205–210. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Estera Okoń Breakdown of academic impact, for papers by Vijay S. Thakur Breakdown of academic impact, for papers by Dong Hou Breakdown of academic impact, for papers by Nikhil Vad Breakdown of academic impact, for papers by Wei Ya Breakdown of academic impact, for papers by Marta Hałas‐Wiśniewska Breakdown of academic impact, for papers by Ajeet Kumar Verma Breakdown of academic impact, for papers by Mi‐Hyeon Jeong Breakdown of academic impact, for papers by Jia-Ni Lin Breakdown of academic impact, for papers by Addanki P. Kumar
Rankless by CCL
2026